Mirabegron and antimuscarinic use in frail overactive bladder patients in the United States Medicare population.

Theodore M Johnson,David Walker,Amy Lockefeer,Baoguo Jiang, David Nimke,Greta Lozano-Ortega,Tomomi Kimura

Neurourology and urodynamics（2022）

引用 2|浏览3

暂无评分

摘要

Among frail older adults with OAB, mirabegron use was associated with higher costs and potential improvements in treatment-taking behaviors, particularly with respect to treatment adherence, versus those initiating antimuscarinics.

查看译文

关键词

adherence,costs,frail,health care resource utilization,persistence

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要